Evidence map›Paper›PMID 32751168›Full record

ArticleBiomolecules2020

Aberrant Membrane Composition and Biophysical Properties Impair Erythrocyte Morphology and Functionality in Elliptocytosis.

Hélène Pollet, Anne-Sophie Cloos, Amaury Stommen, Juliette Vanderroost, Louise Conrard, Adrien Paquot, Marine Ghodsi, Mélanie Carquin, Catherine Léonard, Manuel Guthmann and 12 more

Open access · goldAbstract read
In one paragraph

Article in Biomolecules, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.2field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors at 3 institutions in 1 country.

Hélène PolletCELL Unit & PICT imaging Platform, de Duve Institute, UCLouvain, 1200 Brussels, Belgium.
Anne-Sophie CloosCELL Unit & PICT imaging Platform, de Duve Institute, UCLouvain, 1200 Brussels, Belgium.
Amaury StommenCELL Unit & PICT imaging Platform, de Duve Institute, UCLouvain, 1200 Brussels, Belgium.
Juliette VanderroostCELL Unit & PICT imaging Platform, de Duve Institute, UCLouvain, 1200 Brussels, Belgium.
Louise ConrardCELL Unit & PICT imaging Platform, de Duve Institute, UCLouvain, 1200 Brussels, Belgium.
Adrien PaquotBioanalysis and Pharmacology of Bioactive Lipids Research Group, Louvain Drug Research Institute, UCLouvain, 1200 Brussels, Belgium.ORCID 0000-0002-4784-3510
Marine GhodsiCELL Unit & PICT imaging Platform, de Duve Institute, UCLouvain, 1200 Brussels, Belgium.
Mélanie CarquinCELL Unit & PICT imaging Platform, de Duve Institute, UCLouvain, 1200 Brussels, Belgium.
Catherine LéonardCELL Unit & PICT imaging Platform, de Duve Institute, UCLouvain, 1200 Brussels, Belgium.
Manuel GuthmannCELL Unit & PICT imaging Platform, de Duve Institute, UCLouvain, 1200 Brussels, Belgium.
Maxime LingurskiCELL Unit & PICT imaging Platform, de Duve Institute, UCLouvain, 1200 Brussels, Belgium.
Christiane VermylenPEDI Unit, Institut de Recherche Expérimentale et Clinique & Saint-Luc Hospital, UCLouvain, 1200 Brussels, Belgium.
Theodore KillianComputational Biology and Bioinformatics Unit, de Duve Institute, UCLouvain, 1200 Brussels, Belgium.
Laurent GattoComputational Biology and Bioinformatics Unit, de Duve Institute, UCLouvain, 1200 Brussels, Belgium.ORCID 0000-0002-1520-2268
Mark RiderPHOS Unit & MASSPROT Proteomics Platform, de Duve Institute, UCLouvain, 1200 Brussels, Belgium.
Sébastien Pyr Dit RuysPHOS Unit & MASSPROT Proteomics Platform, de Duve Institute, UCLouvain, 1200 Brussels, Belgium.ORCID 0000-0002-5449-1541
Didier VertommenPHOS Unit & MASSPROT Proteomics Platform, de Duve Institute, UCLouvain, 1200 Brussels, Belgium.ORCID 0000-0001-7648-8282
Miikka VikkulaHuman Molecular Genetics, de Duve Institute, UCLouvain, 1200 Brussels, Belgium.ORCID 0000-0002-6236-338X
Pascal BrouillardHuman Molecular Genetics, de Duve Institute, UCLouvain, 1200 Brussels, Belgium.
Patrick Van Der SmissenCELL Unit & PICT imaging Platform, de Duve Institute, UCLouvain, 1200 Brussels, Belgium.
Giulio G MuccioliBioanalysis and Pharmacology of Bioactive Lipids Research Group, Louvain Drug Research Institute, UCLouvain, 1200 Brussels, Belgium.ORCID 0000-0002-1600-9259
Donatienne TytecaCELL Unit & PICT imaging Platform, de Duve Institute, UCLouvain, 1200 Brussels, Belgium.ORCID 0000-0002-7334-2648
de Duve Institute · BESolvay (Belgium) · BECliniques Universitaires Saint-Luc · BE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Red blood cell (RBC) deformability is altered in inherited RBC disorders but the mechanism behind this is poorly understood. Here, we explored the molecular, biophysical, morphological, and functional consequences of α-spectrin mutations in a patient with hereditary elliptocytosis (pEl) almost exclusively expressing the Pro260 variant of SPTA1 and her mother (pElm), heterozygous for this mutation. At the molecular level, the pEI RBC proteome was globally preserved but spectrin density at cell edges was increased. Decreased phosphatidylserine vs. increased lysophosphatidylserine species, and enhanced lipid peroxidation, methemoglobin, and plasma acid sphingomyelinase (aSMase) activity were observed. At the biophysical level, although membrane transversal asymmetry was preserved, curvature at RBC edges and rigidity were increased. Lipid domains were altered for membrane:cytoskeleton anchorage, cholesterol content and response to Ca

Indexed as

CholesterolElliptocytosis, HereditaryErythrocyte MembraneErythrocytesHumansLysophospholipidsMembrane FluidityMembrane MicrodomainsOxidative StressCholesterollysophosphatidylserineLysophospholipidsamitriptylineCa2+lipid domainslysophosphatidylserinemembrane asymmetrymembrane curvaturemembrane rigidityoxidative stressspectrin cytoskeleton

Identifiers

PMID32751168
PMCPMC7465299
OpenAlexW3045734190

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.